| 영문 | beta human chorionic gonadotropin | 한글 | 베타 사람융모성 생식샘자극호르몬 |
|---|---|---|---|
| 설명 | 태반세포에서 만들어지는 호르몬. 기능은 임신의 초기에 황체(원래 난자를 싸고 있던 세포들이 배란이 일어나서 난자가 빠져나간 후 주머니 모양을 이룬 것. 임신초기에 임신의 유지에 필요한 호르몬을 생성한다)의 유지에 기여하고, 태아의 고환조직에서 남성호르몬이 분비되는 것을 촉진시킨다. 또 이것은 임신초기의 임산부의 소변에서 많은 양이 검출되므로 이것을 이용해서 임신의 여부를 손쉽게 조사할 수가 있다. |
||
| CAS | calcarine sulcus; calcific aortic stenosis; Cancer Attitude Survey; carbohydrate-active steroid; car... |
|---|---|
| CES-D | Center for Epidemiological Studies of Depression [scale] |
| CHAS | Center for Health Administration Studies |
| HCSD | Health Care Studies Division |
| MSU | maple sugar urine; maple syrup urine; medical studies unit; mid-stream urine; monosodium urate; myoc... |
| CES-D | Center for Epidemiologic Studies - Depression |
|---|---|
| CES-D | Center for Epidemiologic Studies - Depression Scale |
| CES-D | Center for Epidemiological Studies Depression |
| CESD | Centers for Epidemiological Studies Depression Scale |
| EPS | Electrophysiologic Studies |
| retrospective studies | Studies used to test aetiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. (12 Dec 1998) |
|---|---|
| pharmalogical studies | <pharmacology> Studies to assess the potential harmful or other effects of drugs (16 Dec 1997) |
| clinical studies | <pharmacology> Human studies that are designed to measure the safety, efficacy, and appropriate dosage of a new drug or biological. Clinical studies routinely involve the use of a placebo group that is given an inactive substance that looks like the test product. (14 Nov 1997) |
| cohort studies | Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesised to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. (12 Dec 1998) |
| combination studies | <pharmacology> Studies in which a new drug is evaluated in combination with existing drugs. (09 Jan 1998) |
| multicenter studies | Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children. (12 Dec 1998) |
| multivariate studies | The use of statistical techniques for the simultaneous investigations of the influence of several variables. (05 Mar 2000) |
| preclinical studies | <pharmacology> Studies in which a drug is tested on animals and in other non-human test systems. Safety information from such studies are used to support an investigational new drug application. (14 Nov 1997) |
| sampling studies | Studies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled. (12 Dec 1998) |
| prospective studies | Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. (12 Dec 1998) |
| his bundle studies | <cardiology> This test studies the electrical activity of the bundle of HIS. The bundle of HIS is a group of electrical fibres in the heart that are responsible for transmitting the electrical impulses which generate a normal cardiac contraction. This test may be performed in cases of cardiac arrhythmias, to locate a specific area responsible for a conduction defect and to determine the need for cardiac pacemaker placement. The test involves the passage of a an electrode tipped catheter into the heart. This catheter is usually threaded through a neck, arm or chest vein. Measurements of the HIS bundle can then be performed while standard ECG leads are placed on the arms and legs. This test carries a small risk of bleeding, arrhythmias, embolism, heart attack and stroke. It is performed by a specially trained cardiologist. (27 Sep 1997) |
| immunofluorescent studies | <technique> A special assay that relies on the production of measurable fluorescent light. An immunofluorescent tagged antibody interacts and binds with an antigen allowing an indirect measurement of its concentration. (27 Sep 1997) |
| intervention studies | Epidemiologic investigations designed to test a hypothesised cause-effect relation by modifying the supposed causal factor(s) in the study population. (12 Dec 1998) |
| intracardiac electrophysiology studies | <cardiology, investigation> A special study that involves the placement of electrodes inside the heart to map the electrical characteristics of the heart. This study is carried out in a specially equipped lab and is similar to a cardiac catheterisation procedure. Electrodes are placed inside the heart via a catheter placed into a vein. The electrodes are positioned near the heart's conduction system and an electrical map of the heart can be determined. This test is often performed in those where a life-threatening cardiac arrhythmia is a problem. The location and characteristics of an arrhythmia can be determined, thus guiding medical management of the problem. Patients with Wolf Parkinson White syndrome or sick sinus syndrome may have this test as part of their evaluation. (27 Sep 1997) |
| organizational case studies | Descriptions and evaluations of specific health care organizations. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|